Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005003 · ClinicalTrials.gov registry record
Genetic Component of Handedness
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 1,400
- Enrollment target
NCT00005003: Completed study, sponsored by National Cancer Institute (NCI).
NCT00005003 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 1,400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005003 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 1,400 participants
- Enrollment target
Study Summary
Some functions are generally controlled by the right side of the brain and others by the left. One of the most easily observed examples of this "lateral specialization" of the brain is handedness-that is, a person's preference for using either the right or the left hand. This study will try to determine how the genetic component of handedness is inherited. It will test the theory that a single gene is involved in determining handedness and will try to locate the gene. Families with at least two left-handed siblings aged eight years or older and at least one right-handed parent are eligible to participate in this study. The left-handed siblings and both parents will fill out a brief questionnaire on hand usage, obtain a tissue sample taken from inside the cheek, and return the questionnaire and the sample by mail to the study researchers. The tissue sample will be used for DNA gene mapping. Participants will be given a kit and instructions for obtaining the sample, along with mailing envelopes. Cheek swab sampling basically involves using a small brush to gently brush a layer of cells off of the inner wall of the cheek and then dropping the brush tip into a preservative. The information gained from this study may provide insight into aspects of brain development that can be of medical benefit in the future.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,400 participants |
| Start Date | 2000-03 |
| Est. Completion | 2006-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00005003
The ClinicalTrials.gov registry entry for NCT00005003 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00005003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00005003 about?
NCT00005003 is a clinical study titled "Genetic Component of Handedness". Some functions are generally controlled by the right side of the brain and others by the left. One of the most easily observed examples of this "lateral specialization" of the brain is handedness-that is, a person's preference for using either the right or the left hand. This study will try to deter...
What is the current status of trial NCT00005003?
This trial is currently completed. The enrollment target is 1,400 participants. The study started on 2000-03. Estimated completion is 2006-04.
Who is sponsoring clinical trial NCT00005003?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.